These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 37802829)

  • 1. [Recent advances in nanocarrier-based drug delivery systems in treatment of rheumatoid arthritis].
    Liang X; Li YL; Bai HT; Zhang QY; Xiao Z; Sun X; Wen WL; Zhang WY; Yang J; Wang R
    Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(18):4874-4883. PubMed ID: 37802829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Delivery System Approaches for Rheumatoid Arthritis Treatment: A Review.
    Garhwal A; Kendya P; Soni S; Kori S; Soni V; Kashaw SK
    Mini Rev Med Chem; 2024; 24(7):704-720. PubMed ID: 37711105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted drug-delivery systems in the treatment of rheumatoid arthritis: recent advancement and clinical status.
    Gorantla S; Singhvi G; Rapalli VK; Waghule T; Dubey SK; Saha RN
    Ther Deliv; 2020 Apr; 11(4):269-284. PubMed ID: 32434463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization of nanoparticle technology in rheumatoid arthritis treatment.
    Dolati S; Sadreddini S; Rostamzadeh D; Ahmadi M; Jadidi-Niaragh F; Yousefi M
    Biomed Pharmacother; 2016 May; 80():30-41. PubMed ID: 27133037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comprehensive review of advanced drug delivery systems for the treatment of rheumatoid arthritis.
    Shen Q; Du Y
    Int J Pharm; 2023 Mar; 635():122698. PubMed ID: 36754181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanomedicine is more than a supporting role in rheumatoid arthritis therapy.
    Han Y; Huang S
    J Control Release; 2023 Apr; 356():142-161. PubMed ID: 36863691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano - Based Therapeutic Strategies in Management of Rheumatoid Arthritis.
    Nautiyal G; Sharma SK; Kaushik D; Pandey P
    Recent Pat Nanotechnol; 2024; 18(4):433-456. PubMed ID: 37904559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Generation Smart Drug Delivery Systems for Rheumatoid Arthritis.
    Singh R; Jadhav K; Vaghasiya K; Ray E; Shukla R; Verma RK
    Curr Pharm Des; 2023; 29(13):984-1001. PubMed ID: 37038685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nano-Based Co-Delivery System for Treatment of Rheumatoid Arthritis.
    Zhang S; Zhang M; Li X; Li G; Yang B; Lu X; Gao Y; Sun F
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent approaches for targeted drug delivery in rheumatoid arthritis diagnosis and treatment.
    Pirmardvand Chegini S; Varshosaz J; Taymouri S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):502-514. PubMed ID: 29661045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology-empowered combination therapy for rheumatoid arthritis: principles, strategies, and challenges.
    Ren S; Xu Y; Dong X; Mu Q; Chen X; Yu Y; Su G
    J Nanobiotechnology; 2024 Jul; 22(1):431. PubMed ID: 39034407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural biomimetic nano-system for drug delivery in the treatment of rheumatoid arthritis: a literature review of the last 5 years.
    Li J; Li W; Zhuang L
    Front Med (Lausanne); 2024; 11():1385123. PubMed ID: 38784236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Nano Carriers for the Treatment of Progressive Auto Immune Disease Rheumatoid Arthritis.
    Mishra R; Gupta S
    Curr Pharm Des; 2021; 27(21):2468-2481. PubMed ID: 33087024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug delivery targets and systems for targeted treatment of rheumatoid arthritis.
    Feng X; Chen Y
    J Drug Target; 2018 Dec; 26(10):845-857. PubMed ID: 29376442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancement in nanotechnology for treatment of rheumatoid arthritis: scope and potential applications.
    Rani R; Raina N; Sharma A; Kumar P; Tulli HS; Gupta M
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2287-2310. PubMed ID: 37166463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining nanotechnology with monoclonal antibody drugs for rheumatoid arthritis treatments.
    Chi XK; Xu XL; Chen BY; Su J; Du YZ
    J Nanobiotechnology; 2023 Mar; 21(1):105. PubMed ID: 36964609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-directed liposomal delivery improves the therapeutic index of an immunomodulatory cytokine in controlling autoimmune arthritis.
    Meka RR; Venkatesha SH; Moudgil KD
    J Control Release; 2018 Sep; 286():279-288. PubMed ID: 30081142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in Formulations of Microneedle System for Rheumatoid Arthritis Treatment.
    Guo P; Huang C; Yang Q; Zhong G; Zhang J; Qiu M; Zeng R; Gou K; Zhang C; Qu Y
    Int J Nanomedicine; 2023; 18():7759-7784. PubMed ID: 38144510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Targeting and Nanotherapeutic Advancement in the Treatment of Rheumatoid Arthritis: Recent Progress in Drug Delivery Systems.
    Deshmukh R
    Curr Pharm Biotechnol; 2024 Jun; ():. PubMed ID: 38910471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural Products for the Treatment of Autoimmune Arthritis: Their Mechanisms of Action, Targeted Delivery, and Interplay with the Host Microbiome.
    Dudics S; Langan D; Meka RR; Venkatesha SH; Berman BM; Che CT; Moudgil KD
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.